USE OF FUSION PROTEIN
    4.
    发明申请
    USE OF FUSION PROTEIN 有权
    使用融合蛋白

    公开(公告)号:US20150337025A1

    公开(公告)日:2015-11-26

    申请号:US14653276

    申请日:2013-12-05

    Abstract: Disclosed is the use of a fusion protein in drugs for stimulating differentiation of bone marrow mesenchymal stem cells to hematopoietic stem/progenitor cells, or drugs for proliferation of granulocyte hematopoietic progenitor cells. The fusion protein has a sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 4. The drugs can be used for the prevention and/or treatment of (i) hematopoietic dysfunction caused by chemotherapy, (ii) hematopoietic dysfunction caused by radiotherapy, or (iii) leukopenia.

    Abstract translation: 公开了在药物中使用融合蛋白来刺激骨髓间充质干细胞分化成造血干细胞/祖细胞或用于粒细胞造血祖细胞增殖的药物。 融合蛋白具有如SEQ ID NO:2或SEQ ID NO:4所示的序列。该药物可用于预防和/或治疗(i)由化疗引起的造血功能障碍,(ii)造血功能障碍引起的 放射治疗,或(iii)白细胞减少。

Patent Agency Ranking